Glempa M 12.5mg/850mg Tablet
₨ 382
About this product
Overview
Glempa M 12.5mg/850mg Tablet is a combination medication containing two active ingredients: Empagliflozin & Metformin. Empagliflozin is classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor, while metformin belongs to the biguanide class of antidiabetic drugs. This combination medication is used to manage type 2 diabetes mellitus.
Active Ingredients
- Empagliflozin: Functions by inhibiting the reabsorption of glucose in the kidneys, resulting in increased urinary excretion of glucose.
- Metformin: Works by decreasing hepatic glucose production, reducing intestinal absorption of glucose, and enhancing insulin sensitivity.
Uses
Glempa M Tablet is indicated for the treatment of type 2 diabetes mellitus in adults. It helps regulate blood sugar levels through different mechanisms: empagliflozin promotes the excretion of glucose in the urine, while metformin reduces hepatic glucose production and improves insulin sensitivity.
Mechanism of Action
- Empagliflozin: Inhibits sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to decreased glucose reabsorption and increased urinary glucose excretion.
- Metformin: Reduces hepatic glucose production, inhibits gluconeogenesis, decreases intestinal absorption of glucose, and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.
Administration
Glempa M Tablet is typically taken orally with meals as directed by a healthcare provider. The dosage may vary based on individual response and other factors. Patients should adhere to the dosage instructions provided by their healthcare provider.
Side Effects
Common side effects of Glempa M Tablet may include:
- Hypoglycemia (low blood sugar)
- Genital yeast infections
- Urinary tract infections
- Increased urination
- Thirst
- Nausea
- Diarrhea
- Abdominal pain
Precautions
Before using Glempa M Tablet, patients should consider the following precautions:
- Inform healthcare providers of any known allergies to empagliflozin, metformin, or other medications.
- Regularly monitor blood sugar levels, especially during initial treatment or dosage adjustments.
- Use caution in patients with kidney problems, dehydration, or hypotension.
- Avoid excessive alcohol consumption, as it may increase the risk of lactic acidosis.
- Inform healthcare providers of any other medications, supplements, or herbal products being taken, as they may interact with empagliflozin or metformin.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Customer reviews
You must be logged in to post a review.




Reviews
Clear filtersThere are no reviews yet.